The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Open accessAbstract
Mimicking Caloric Restriction: The extended life span and resistance to age-related diseases in animals exposed to caloric restriction has focused attention on the biochemical mechanisms that produce these effects. Selman et al. (p. 140 ; see the Perspective by Kaeberlein and Kapahi ) explored the role of the mammalian ribosomal protein S6 kinase 1 (S6K1), which regulates protein translation and cellular energy metabolism. Female knockout mice lacking expression of S6K1 showed characteristics of animals exposed to caloric restriction, including improved health and increased longevity. The beneficial effects included reduced fat mass in spite of increased food intake. Thus, inhibition of signaling pathways activated by S6K1 might prove beneficial in protecting against age-related disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mice deficient in S6K1 (a main mTORC1 substrate) are also long-lived”
From The Hallmarks of Aging (2013) · cites this paper as Selman et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even partial inhibition of mTORC1 in genetic mouse models (e.g., S6K1−/−, mTOR+/− mLST8+/−, mTORΔ/Δ, TSC1tg) can extend lifespan and healthspan in mice 13,17–19.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in mice have likewise shown that genetic depletion of mTORC1 subunits, deletion of S6K1 or downstream substrates, or expression of dominant negative 4E-BP1 in specific tissues extends the lifespan and healthspan of mice 13–16.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, similar evidence does not exist yet for the effects of rapamycin on mammalian aging, and other mechanisms such as inhibition of the ribosomal S6 protein kinase 1 (S6K1) implicated in protein synthesis (Selman et al., 2009), could contribute to explain the pro-longevity effects of rapamycin (see section on Deregulated Nutrient-sensing).”
From The Hallmarks of Aging (2013) · cites this paper as Selman et al., 2009
In the citing paper
“Depletion of ribosome subunits or interference with the target of rapamycin/ribosomal protein S6 kinase pathway, which functions to activate protein translation, were found to alter the lifespan of a variety of species including mammals (54–56).”
From Controlled DNA double-strand break induction in mice reveals post-damage transcriptome stability (2016) · cites this paper as [55]
In the citing paper
“and mice deficient in S6K1 (a main mTORC1 substrate) are also long lived.221”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Self-citationAMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,042
Greer, E. L., Dowlatshahi, D., Banko, M. R., Villen, J., Hoang, K., Blanchard, D., Gygi, S. P., & Brunet, A. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.047 · Cited by 801
Functionally significant insulin-like growth factor I receptor mutations in centenarians
Suh, Y., Atzmon, G., Cho, M.-O., Hwang, D., Liu, B., Leahy, D. J., Barzilai, N., & Cohen, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705467105 · Cited by 703
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1
Um, S. H., D'Alessio, D., & Thomas, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.003 · Cited by 690
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 999
Jurca, C. M., Kozma, K., Petcheși, C. D., Zaha, D. C., Magyar, I., Munteanu, M. A., Faur, L., Jurca, A. A., Bembea, D., Severin, E. M., et al. (2023) · Genes · doi:10.3390/genes14020433 · Cited by 21
“have shown that S6K1 depletion improves insulin sensitivity in mice, while the activation of the mTOR complex produces dysfunctions in the insulin signaling pathway and insulin resistance sets in [44,45].”
BackgroundDistinct regulation of Maf1 for lifespan extension by Protein kinase A and Sch9
Cai, Y., & Wei, Y. (2015) · Aging · doi:10.18632/aging.100727 · Cited by 20
“Sch9/S6K1 is broadly involved in lifespan regulation: deletion or knockdown of Sch9/S6K1 can extend lifespan in yeast [13, 14], worms [15, 16], flies [17] and mice [18].”
BackgroundControl of hyperglycemia in male mice by leflunomide: mechanisms of action
Chen, J., Sun, J. F., Doscas, M. E., Ye, J., Williamson, A. J., Li, Y., Li, Y., Prinz, R. A., & Xu, X. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0536 · Cited by 20
Factors that affect the translation of dietary restriction into a longer life
von Frieling, J., & Roeder, T. (2019) · IUBMB Life · doi:10.1002/iub.2224 · Cited by 22
Teng, Y., Wang, J.-Y., Chi, Y., & Tsai, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239059 · Cited by 20
“Moreover, an indirect suppression of Irs1 and Irs2 via inactivation of S6K1 (ribosomal protein S6 kinase 1) in mice was found to lead to an increased lifespan [50].”
BackgroundChen, Z., Mao, Z., Tang, W., Shi, Y., Liu, J., & You, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00517-1 · Cited by 27
Future foods, dietary factors and healthspan
Li, K., Wang, C., Wang, Y., Fu, L., & Zhang, N. (2023) · Journal of Future Foods · doi:10.1016/j.jfutfo.2022.12.001 · Cited by 20
Hoshino, S., Kobayashi, M., & Higami, Y. (2018) · Aging · doi:10.18632/aging.101557 · Cited by 20
“In addition, ribosomal protein S6 kinase KO mice and mTOR mutant mice also lived longer than wildtype mice [19, 20].”
BackgroundMota‐Martorell, N., Jové, M., Pradas, I., Berdún, R., Sánchez, I. P., Naudí, A., Garí, E., Barja, G., & Pamplona, R. (2020) · GeroScience · doi:10.1007/s11357-020-00210-3 · Cited by 19
“…of Genetics, Physiology and Microbiology, Complutense University of Madrid (UCM), 28040 Madrid, Spain e-mail: gbarja@bio.ucm.es longevity (Selman et al. 2009; Wu et al. 2013; Fushan et al. 2015; Ma and Gladyshev 2017; Sahm et al. 2018), and the same is true of studies comparing animal…”
BackgroundRapamycin: Killing two birds with one stone
Khanna, A., & Kapahi, P. (2011) · Aging · doi:10.18632/aging.100405 · Cited by 19
Gerashchenko, M. V., Nesterchuk, M. V., Smekalova, E. M., Paulo, J. A., Kowalski, P. S., Akulich, K. A., Bogorad, R. L., Dmitriev, S. E., Gygi, S. P., Zatsepin, T. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72399-4 · Cited by 17
Geroprotective effects of Alzheimer’s disease drug candidates
Kepchia, D., Currais, A. J. M., Dargusch, R., Finley, K. D., Schubert, D. A., & Maher, P. A. (2021) · Aging · doi:10.18632/aging.202631 · Cited by 19
Principles of brain aging: Status and challenges of modeling human molecular changes in mice
Kluever, V., & Fornasiero, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101465 · Cited by 18
Regulation of Aging and Longevity by Ion Channels and Transporters
Venkatachalam, K. (2022) · Cells · doi:10.3390/cells11071180 · Cited by 20
Pharmacological Approaches to Decelerate Aging: A Promising Path
Hassani, B., Goshtasbi, G., Nooraddini, S., & Firouzabadi, N. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4201533 · Cited by 19
“A study that was performed in vivo showed that homozygous mutation in ribosomal S6 protein kinase 1 (S6K1) increases lifespan [93]. mTOR can also be involved in the regulation of autophagy via the Unc-51-Like Autophagy Activating Kinase 1 (ULK1) pathway [94]. mTORC2 has the ability to control…”
Polyploidy and mTOR signaling: a possible molecular link
Choudhury, D., Ghosh, D., Mondal, M., Singha, D., Pothuraju, R., & Malakar, P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01526-9 · Cited by 20
“2) [138].”
Ogawa, T., Shibato, J., Rakwal, R., Saito, T., Tamura, G., Kuwagata, M., & Shioda, S. (2014) · Congenital Anomalies · doi:10.1111/cga.12062 · Cited by 19
“…1 (s6k1), a component of the nutrientresponsive mTOR signaling pathway also led to increased life span and resistance to age-related pathologies (Selman et al. 2009). mTOR was reported to be a central player in the effect of maternal undernutrition on the baboon kidney (Nijland et al. 2007).…”
BackgroundDrug Synergy Drives Conserved Pathways to Increase Fission Yeast Lifespan
Huang, X., Leggas, M. L., & Dickson, R. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121877 · Cited by 18
“cerevisiae [29, 30] and S6K1 and S6K2 in mammals [31, 32].”
Insulin stimulates IGFBP-2 expression in 3T3-L1 adipocytes through the PI3K/mTOR pathway
Li, Z., Miard, S., Laplante, M., Sonenberg, N., & Picard, F. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.022 · Cited by 18
Recent discoveries in the cycling, growing and aging of the p53 field
McCubrey, J. A., & Demidenko, Z. N. (2012) · Aging · doi:10.18632/aging.100529 · Cited by 18
“As recently proposed, aging is not caused by accumulation of DNA damage but is driven by signaling pathways such as TOR [13-36].”
Selman, C., Sinclair, A., Pedroni, S. M. A., Irvine, E. E., Michie, A. M., & Withers, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8729 · Cited by 18
Self-citationLiao, C., Anderson, S. S., Chicoine, N. H., Mayfield, J., Garrett, B., Kwok, C. S., Academia, E. C., Hsu, Y.-M., Miller, D. M., Bair, A. M., et al. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.39 · Cited by 19
Self-citationGhosh, A. K., Mau, T., O’Brien, M., & Yung, R. L. (2018) · Aging · doi:10.18632/aging.101426 · Cited by 18
“b) fat cell insulin receptor knock out (FIRKO), insulin receptor substrate (IRS-1) or S6 kinase 1 knockout mice models [21, 22].”
BackgroundLong-lived Humans Have a Unique Plasma Sphingolipidome
Pradas, I., Jové, M., Huynh, K., Inglés, M., Borrás, C., Mota‐Martorell, N., Galo‐Licona, J. D., Puig, J., Viña, J., Meikle, P. J., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab360 · Cited by 19
TORC1 Signaling in Budding Yeast
Loewith, R. (2010) · The Enzymes · doi:10.1016/s1874-6047(10)27009-9 · Cited by 19
“This idea is supported and extended to other eukaryotes, including vertebrates, by several recent publications [3, 94–96].”
BackgroundResultThe 1,25D3‐MARRS receptor/PDIA3/ERp57 and lifespan
Nemere, I., Garbi, N., & Winger, Q. A. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24986 · Cited by 18
“Signaling pathways for life span regulators have been reported to work through mTOR and S6 kinase [Selman et al., 2009].”
BackgroundYamashita, H., Kusudo, T., Takeuchi, T., Qiao, S., Tsutsumiuchi, K., Wang, T., & Wang, Y. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.09.032 · Cited by 20
Accumulation of prelamin A induces premature aging through mTOR overactivation
Pan, X., Jiang, B., Wu, X., Xu, H., Cao, S., Bai, N., Li, X., Yi, F., Guo, Q., Guo, W., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201903048rr · Cited by 18
Targeting the Electron Transport System for Enhanced Longevity
Radovic, M., Gartzke, L. P., Wink, S. E., van der Kleij, J. A., Politiek, F. A., & Krenning, G. (2025) · Biomolecules · doi:10.3390/biom15050614 · Cited by 17
mTOR regulates GPVI-mediated platelet activation
Wang, L., Liu, G., Wu, N., Dai, B., Han, S., Liu, Q., Huang, F., Chen, Z., Xu, W., Xia, D., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02756-y · Cited by 17
Branicky, R. S., Wang, Y., Khaki, A., Liu, J., Kramer‐Drauberg, M., & Hekimi, S. (2022) · Science Advances · doi:10.1126/sciadv.adc9851 · Cited by 16
Li, X., Khan, D., Rana, M., Hänggi, D., & Muhammad, S. (2022) · Antioxidants · doi:10.3390/antiox11122413 · Cited by 16
Lost in translation: challenges of current pharmacotherapy for sarcopenia
Tsai, S. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.016 · Cited by 19
Papatheodorou, I., Petrovs, R., & Thornton, J. M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu493 · Cited by 17
Self-citationExploiting Post-mitotic Yeast Cultures to Model Neurodegeneration
Ruetenik, A., & Barrientos, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00400 · Cited by 18
Dai, D., Liu, Y., Basisty, N., Karunadharma, P. P., Dastidar, S. G., Chiao, Y. A., Chen, T., Beyer, R. P., Chin, M. T., MacCoss, M. J., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00119-6 · Cited by 17
S6K1 controls adiponectin expression by inducing a transcriptional switch: BMAL1-to-EZH2
Yi, S. A., Jeon, Y. J., Lee, M. G., Nam, K. H., Ann, S.-R., Lee, J., & Han, J. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00747-7 · Cited by 17
Morris, B. J., Donlon, T. A., He, Q., Grove, J., Masaki, K., Elliott, A., Willcox, D. C., Allsopp, R., & Willcox, B. J. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu021 · Cited by 17
“Rapamycin reduces mTORmediated phosphorylation of RPS6KA1 (16), so increasing life span and resistance to age-related pathologies, as well as producing gene expression patterns similar to those seen in caloric restriction or pharmacological activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), a…”
BackgroundVelázquez-Arellano, A., Ortega-Cuéllar, D., Hernández-Mendoza, A., & Moreno-Arriola, E. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.08.021 · Cited by 17
“An analogous effect has been observed in mammals where S6 kinases 1 and 2 (S6K1/2), transducing nutritional anabolic signals mediated by mTOR [51], activate AMPK in association with increased AMP/ATP ratio [52].”
BackgroundCombinatorial Approach Using Caenorhabditis elegans and Mammalian Systems for Aging Research
Lee, G., Sohn, J., & Lee, S. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0080 · Cited by 16
Ortega-Molina, A., Lebrero‐Fernández, C., Sanz, A., Deleyto-Seldas, N., Plata-Gómez, A. B., Menéndez, C., Graña‐Castro, O., Caleiras, E. J., & Efeyan, A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109372 · Cited by 18
“…signaling, and it is conceivable that a certain threshold of inhibition of mTORC1 signaling must be reached to reveal its longevity-promoting effects, as seen genetically in mice expressing a mTOR hypomorph allele (Wu et al., 2013) or in S6K1 homozygous knockout female mice (Selman et al., 2009).”
Kim, J. W., Nam, S. A., Koh, E. S., Kim, H. W., Kim, S., Woo, J. J., & Kim, Y. K. (2024) · Antioxidants · doi:10.3390/antiox13080886 · Cited by 16
“Deficiency in Atg1, Atg7, Atg18, and Beclin 1 decreases the life span of the nematode Caenorhabditis elegans [43], and the deficient expression in Atg1, Atg8, and Sestrin1 reduces the life span of the fruit fly Drosophila melanogaster [45,46].”
BackgrounddRAGging Amino Acid-mTORC1 Signaling by SH3BP4
Kim, Y. M., & Kim, D. (2012) · Molecules and Cells · doi:10.1007/s10059-013-2249-1 · Cited by 17
“…et al., 2002; Jung et al., 2010; Kim et al., 2002; Loewith et al., 2002). mTORC1 is highly activated in many cancers, and its activity is deregulated in diabetes, obesity and aging (Goberdhan and Boyd, 2009; Harrison et al., 2009; Selman et al., 2009; Um et al., 2004; Wullschleger et al., 2006).”
BackgroundGrowth Culture Conditions and Nutrient Signaling Modulating Yeast Chronological Longevity
Santos, J., Leão, C., & Sousa, M. J. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/680304 · Cited by 16
“IGF-1 and insulin also modulate TOR activity through Akt kinase which is a downstream effector of the insulin/IGF-1 pathway [23], and inhibition of mTOR pathway by rapamycin [24] or deletion of its downstream effector S6K, increases mice lifespan [25].”
BackgroundLi, Y., Zhang, J., & Yang, C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.008 · Cited by 16
A Reassessment of Genes Modulating Aging in Mice Using Demographic Measurements of the Rate of Aging
de Magalhães, J. P., Thompson, L. M., de Lima, I., Gaskill, D., Li, X., Thornton, D., Yang, C., & Palmer, D. H. (2018) · Genetics · doi:10.1534/genetics.118.300821 · Cited by 17
TOR links starvation responses to telomere length maintenance
Kupiec, M., & Weisman, R. (2012) · Cell Cycle · doi:10.4161/cc.20401 · Cited by 17
Senotherapy for chronic lung disease
Barnes, P. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100069 · Cited by 17
“Deletion of S6K1 prolongs the life-span of mice (Selman et al, 2009) and reduces liver in fl ammation, but does not appear to reduce senescence (Gallage et al, 2024).”
Cardiac aging: Molecular mechanisms and therapeutic interventions
Li, X., Pang, X., Sun, H., Zhang, B., Wang, H., Wu, N., & Yang, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107954 · Cited by 16
Papatheodorou, I., Ziehm, M., Wieser, D., Alic, N., Partridge, L., & Thornton, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050881 · Cited by 15
Self-citationMORG1 limits mTORC1 signaling by inhibiting Rag GTPases
Abudu, Y. P., Kournoutis, A., Brenne, H. B., Lamark, T., & Johansen, T. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.023 · Cited by 17
Mason, A. G., Garza, R. M., McCormick, M. A., Patel, B., Kennedy, B. K., Pillus, L., & Spada, A. R. L. (2017) · Aging Cell · doi:10.1111/acel.12611 · Cited by 15
Ageing, Drosophila melanogaster and Epigenetics
Halim, M. A., Tan, F. H. P., Azlan, A., Rasyid, I. I., Rosli, N., Shamsuddin, S., & Azzam, G. (2020) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2020.27.3.2 · Cited by 17
“4EBP was shown to interact with rapamycin, hence, modulating lifespan (55) while knocked-down S6 kinase literally extend the lifespan in both flies (54) and mice (58).”
BackgroundRodent diet aids and the fallacy of caloric restriction
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111584 · Cited by 15
The Aging Adipose Organ: Lipid Redistribution, Inflammation, and Cellular Senescence
Stout, M. B., Tchkonia, T., & Kirkland, J. L. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_5 · Cited by 15
Das, P., Aballay, A., & Singh, J. (2023) · eLife · doi:10.7554/elife.89572 · Cited by 15
Shyu, Y., Liao, P.-C., Huang, T., Yang, C., Lu, M., Huang, S., Lin, X., Liou, C., Kao, Y.-J., Lu, C.-H., et al. (2022) · Advanced Science · doi:10.1002/advs.202201409 · Cited by 12
Geroprotective interventions in the 3xTg mouse model of Alzheimer’s disease
Sonsalla, M. M., & Lamming, D. W. (2023) · GeroScience · doi:10.1007/s11357-023-00782-w · Cited by 17
Responses to Many Anti-Aging Interventions Are Sexually Dimorphic
Bartke, A., Hascup, E. R., & Hascup, K. N. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.230015 · Cited by 13
“Further support for these broad generalizations was provided by the demonstration that deletion of ribosomal protein S6 kinase 1, which is activated by IIS can also extend longevity [50].”
BackgroundSch9 regulates intracellular protein ubiquitination by controlling stress responses
Beibei, Q. I. E., Lyu, Z., Lyu, L., Liu, J., Gao, X., Liu, Y., Duan, W., Zhang, N., Du, L., & Liu, K. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.002 · Cited by 16
“Our results revealed for the first time how Sch9 regulates the level of ubiquitinated proteins and provides new insight into how Sch9 controls longevity.”
Klingebiel, M., Dinekov, M., & Köhler, C. N. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.016 · Cited by 15
Age-associated molecular changes are deleterious and may modulate life span through diet
Lee, S., Kaya, A., Avanesov, A. S., Podolskiy, D. I., Song, E. J., Go, D., Jin, G.-D., Hwang, J. Y., Kim, E. B., Kim, D.-Y., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601833 · Cited by 14
“Similarly, reduced activity of the insulin-signaling pathway (31) and the mTOR pathway by deletion of S6K (32) extended the life span only in females.”
BackgroundALA-PDT suppressed the cell growth by Akt-/Erk-mTOR-p70 s6k pathway in human SZ95 sebocytes in vitro
Liu, W., Wang, Q., Tuo, J., Chang, Y., Ying, J., Jiang, M., Zouboulis, C. C., & Xiang, L. F. (2018) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2018.06.024 · Cited by 14
Pharmaceutical Intervention of Aging
Qian, M., & Liu, B. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_15 · Cited by 17
Li, J., Duan, D., Zhang, J., Zhou, Y., Qin, X., Du, G., & Gao, L. (2019) · Molecular Genetics and Genomics · doi:10.1007/s00438-019-01589-1 · Cited by 14
Aminoacyl-tRNA synthetases in cell signaling
Yao, P., & Fox, P. L. (2020) · The Enzymes · doi:10.1016/bs.enz.2020.04.002 · Cited by 16
Infante, B., Bellanti, F., Correale, M., Pontrelli, P., Franzin, R., Leo, S., Calvaruso, M., Mercuri, S., Netti, G. S., Ranieri, E., et al. (2021) · Aging · doi:10.18632/aging.202863 · Cited by 14
Mitsuishi, M., Miyashita, K., Muraki, A., Tamaki, M., Tanaka, K., & Itoh, H. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00145.2013 · Cited by 14
Potter, S., Sifers, J., Yocom, E., Blümich, S. L. E., Potter, R., Nadolski, J., Harrison, D. A., & Cooper, R. L. (2019) · Biology Open · doi:10.1242/bio.046508 · Cited by 14
Development of Akt-activated GSK3β inhibitory peptide
Kim, J., Piao, S., Lee, E., Yoon, B., Moon, H. R., Lee, J., Jung, Y., & Ha, N. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.103 · Cited by 15
Kapahi, P., & Vijg, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmcibr0909815 · Cited by 14
Wang, H., Ramshekar, A., Cung, T., Wallace‐Carrete, C., Zaugg, C. J., Nguyen, J., Stoddard, G. J., & Hartnett, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210276 · Cited by 13
Aging, longevity, and the role of environmental stressors: a focus on wildfire smoke and air quality
Scieszka, D. P., Bolt, A. M., McCormick, M. A., Brigman, J. L., & Campen, M. J. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.1267667 · Cited by 15
RETRACTED: Ferroptosis and aerobic training in ageing
Kordi, N., Saydi, A., Karami, S., Bagherzadeh-Rahmani, B., Marzetti, E., Jung, F., & Stockwell, B. R. (2024) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-232076 · Cited by 13
“Deletion of the downstream target of mTOR, S6K, increases lifespan in female mice, while knocking out mTOR is lethal [80].”
RetractedThe Biological Mechanisms of Aging: A Historical and Critical Overview
Goto, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_1 · Cited by 15
Zaini, M. A., Müller, C., Ackermann, T., Reinshagen, J., Kortman, G., Pleß, O., & Calkhoven, C. F. (2017) · Scientific Reports · doi:10.1038/srep42603 · Cited by 14
Metabolic Regulation of Stem Cells in Aging
Keller, A. R., Temple, T., Sayanjali, B., & Mihaylova, M. M. (2021) · Current Stem Cell Reports · doi:10.1007/s40778-021-00186-6 · Cited by 14
mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity
Mota‐Martorell, N., Jové, M., & Pamplona, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158747 · Cited by 13
Jäger, K., Mensch, J., Grimmig, M., Neuner, B., Gorzelniak, K., Türkmen, S., Demuth, I., Hartmann, A., Hartmann, C., Wittig, F., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk2814 · Cited by 13
“However, most findings so far were obtained by use of genetic manipulation in mice (53, 54) and flies (55) or mTOR inhibition in human and rodent cell lines or in Caenorhabditis elegans.”
Wang, L., Derous, D., Huang, X., Mitchell, S. E., Douglas, A., Lusseau, D., Wang, Y., & Speakman, J. R. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad017 · Cited by 13
“Inhibition of the mTOR signaling pathway increased the life span of model organisms and protected them against age-related diseases (12), while knocking out the downstream ribosomal protein S6 kinase 1 (S6K1) from mTOR signaling extended the life span in mouse (17).”
BackgroundLifespan and Glucose Metabolism in Insulin Receptor Mutant Mice
Shimizu, T., Baba, T., OGAWARA, M., & Shirasawa, T. (2011) · Journal of Aging Research · doi:10.4061/2011/315640 · Cited by 12
“also reported that deletion of ribosomal S6 protein kinase (S6K), a component of the nutrient-responsive mTOR (mammalian target of rapamycin) signaling pathway, led to an increased lifespan and loss of insulin sensitivity [34].”
BackgroundFlorido, R., Tchkonia, T., & Kirkland, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00005-1 · Cited by 14
Mołoń, M., & Żebrowski, J. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox031 · Cited by 13
“…public mechanisms, highly conserved genes and metabolic pathways exist in a whole group of organisms, e.g. calorie restriction (Rona et al. 2015), sirtuins (Tissenbaum and Guarente 2001; Burnett et al. 2011; Kanfi et al. 2012), S6 kinase (Fabrizio et al. 2004; Pan et al. 2007; Selman et al. 2009).”
Slm35 links mitochondrial stress response and longevity through TOR signaling pathway
Aguilar-Lopez, J. L., Laboy, R., Jaimes‐Miranda, F., Garay, E., DeLuna, A., & Funes, S. (2016) · Aging · doi:10.18632/aging.101093 · Cited by 13
“The mammalian ortholog of Sch9, the ribosomal S6 kinase 1 (S6K1), influences lifespan and age-related pathologies [20].”
Topisirović, I., & Sonenberg, N. (2010) · Science · doi:10.1126/science.1187497 · Cited by 13
Hyperactive mTORC1/4EBP1 signaling dysregulates proteostasis and accelerates cardiac aging
Zarzycka, W., Kobak, K. A., King, C. J., Peelor, F. F., Miller, B. F., & Chiao, Y. A. (2024) · GeroScience · doi:10.1007/s11357-024-01368-w · Cited by 12
“S6K1 and 4EBP1, on the other hand, control protein synthesis [32, 34]. mTORC1 phosphorylates 4EBP1, which suppresses its binding to eukaryotic initiation factor 4E (eIF4E), releasing eIF4E for the initiation of cap-dependent translation [31].”
Understanding Vascular Diseases: Lessons From Premature Aging Syndromes
Ikeda, Y., Kumagai, H., Motozawa, Y., Suzuki, J.-I., Akazawa, H., & Komuro, I. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.12.003 · Cited by 12
Differential control of ageing and lifespan by isoforms and splice variants across the mTOR network
Navas, P. R., & Thedieck, K. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160086 · Cited by 13
Candidate Genes That Affect Aging Through Protein Homeostasis
Argon, Y., & Gidalevitz, T. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2404-2_2 · Cited by 13
Role of mismatch repair in aging
Wen, J., Wang, Y., Yuan, M., Huang, Z., Zou, Q., Pu, Y., Zhao, B., & Cai, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64953 · Cited by 14
Dietary interventions and molecular mechanisms for healthy musculoskeletal aging
Murphy, A. W., Vyavahare, S. S., Kumar, S., Lee, T. J., Sharma, A. K., Adusumilli, S., Hamrick, M. W., Isales, C. M., & Fulzele, S. (2022) · Biogerontology · doi:10.1007/s10522-022-09970-1 · Cited by 13
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging, or Vice Versa?
Sharp, Z. D., Curiel, T. J., & Livi, C. B. (2013) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000343625 · Cited by 11
Energy restriction impairs dendritic cell development in C57BL/6J mice
Duriancik, D. M., & Gardner, E. M. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.02.002 · Cited by 12
Eudesmin impairs adipogenic differentiation via inhibition of S6K1 signaling pathway
Nam, K. H., Yi, S. A., Lee, J., Lee, M. G., Park, J. H., Oh, H., Lee, J., Park, J. W., & Han, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.188 · Cited by 12
Recent advances in vertebrate aging research 2009
Austad, S. N. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00565.x · Cited by 12
Modelling age-related metabolic disorders in the mouse
Goldsworthy, M. E., & Potter, P. K. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9539-6 · Cited by 12
“Lifetime studies are confounded by expense but a detailed phenotypic pipeline may reveal mutations preventing obesity or other adverse conditions such as ageing and thus may represent mutations resulting in health benefits (Selman et al. 2008, 2009).”
BackgroundHwang, H. J., Kang, D., Kim, J., Choi, J. H., Ryu, J., Herman, A. B., Ko, Y., Park, H. J., Gorospe, M., & Lee, J. (2024) · JCI Insight · doi:10.1172/jci.insight.172678 · Cited by 13
“In recent decades, there has been a growing interest in the role of mTOR as a regulator of life span and aging (38–40).”
BackgroundCharacterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans
Zhang, A., Meecham-Garcia, G., Hong, C. N., Xie, P., Kern, C. C., Zhang, B., Chapman, H., & Gems, D. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae196 · Cited by 11
Self-citationmTOR Regulates T-Cell Differentiation and Activation in Immunity and Autoimmunity
Bi, Y., Liu, G., & Yang, R. (2011) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i4.20 · Cited by 11
Page, M. M., Schuster, E. F., Mudaliar, M., Herzyk, P., Withers, D. J., & Selman, C. (2018) · Aging · doi:10.18632/aging.101446 · Cited by 11
“While significant commonality appears to exist between the transcriptional profiles of DR mice and certain long-lived mutants [14,33,34], little overlap was observed in plasma metabolites identified in a comparative metabonomic study of DR mice, insulin receptor substrate 1 null (Irs1) mice and Ames dwarf mice [35].”
BackgroundResultSelf-citation
Metadata
- Authors
- Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., Woods, A., Robinson, I. C. A., Schuster, E., Batterham, R. L., Kozma, S. C., Thomas, G., Carling, D., Okkenhaug, K., Thornton, J. M., Partridge, L., Gems, D., & Withers, D. J.
- Affiliations
- University College London (GB)
- European Bioinformatics Institute (GB)
- Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK.
- Medical Research Council (GB)
- Babraham Institute (GB)
- Imperial College London (GB)
- University of Cincinnati (US)
- Corresponding author
- Selman, Colin
- Withers, Dominic J.
- ORCID
- Venue
- Science
- Published
- 2009-10-02
- Volume
- 326
- Issue
- 5949
- Pages
- 140-144
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4954603
- OpenAlex
- W2014892893
- Cited by
- 1,120
- References
- 29
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 38 · 2023: 64 · 2022: 50 · 2021: 59 · 2020: 57 · 2019: 58 · 2018: 73 · 2017: 65 · 2016: 57 · 2015: 82 · 2014: 84 · 2013: 90 · 2012: 107
- FWCI
- 29.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Kent Academic Repository (University of Kent) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust (066750)
- Biotechnology and Biological Sciences Research Council (BBS/E/B/0000C236, BBS/E/B/0000M979)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- ribosomal protein S6 kinase 1, mTOR signaling, caloric restriction, aging, lifespan, AMPK, age-related bone loss, immune dysfunction, motor impairment, insulin resistance
- MeSH terms
- Aging, Animals, Female, Gene Expression Regulation, Insulin, Liver, Longevity, Male, Mice, Inbred C57BL, Motor Activity, Protein Kinases, Transcription, Genetic, Signal Transduction, Bone Density, Gene Expression, T-Lymphocyte Subsets, Gene Deletion, Muscle, Skeletal, Caloric Restriction, Ribosomal Protein S6 Kinases, 90-kDa, Mice, Adipose Tissue, White, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
